Literature DB >> 1254691

Triiodothyronine and thyroxine in urine. II. Renal handling, and effect of urinary protein.

C W Burke, R A Shakespear.   

Abstract

Mean urinary clearances of T3 were 164 ml/min in normal subjects, 177 in pregnancy, 221 in thyrotoxicosis, 174 in hypothyroidism, and 194 in 3 persons with undetectable T4 but normal T3 levels. T4 clearances were 38 ml/min in normal subjects, 48 in thyrotoxicosis, and 138 in hypothyroidism. Low creatinine clearance was associated with low clearances of T4 and T3. The data suggest urinary excretion of T3 by glomerular filtration of serum unbound T3 with added tubular excretion; and T4 excretion by glomerular filtration of unbound T4 and tubular reabsorption. However, 3-9% of urinary T3 and 5-12% of urinary T4 were bound to urinary proteins, and increased protein excretion caused markedly increased T4 excretion. In addition, 52% of urinary T3 and 68% of urinary T4 were bound to other substances of approximate mol wt 500-2,000, which may influence tubular handling of T3 or T4.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1254691     DOI: 10.1210/jcem-42-3-504

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  3 in total

1.  Increased levothyroxine requirements presenting as "inappropriate" TSH secretion syndrome in a patient with nephrotic syndrome.

Authors:  M T Collins; A T Remaley; G Csako; F Pucino; M C Skarulis; J E Balow; N J Sarlis
Journal:  J Endocrinol Invest       Date:  2000-06       Impact factor: 4.256

2.  Severe hypothyroidism associated with the degree of edema in a patient with nephrosis.

Authors:  Hiroyuki Kinoshita; Amiko Ishii; Akiko Hayakawa; Mutsuko Yasuda; Seiji Inoshita; Fumiatsu Yakushiji
Journal:  Clin Pract       Date:  2011-10-13

3.  Association between albuminuria and thyroid function in patients with chronic kidney disease.

Authors:  Walter Reinhardt; Nils Mülling; Stefan Behrendt; Sven Benson; Sebastian Dolff; Dagmar Führer; Susanne Tan
Journal:  Endocrine       Date:  2021-02-11       Impact factor: 3.633

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.